You're viewing a public preview of Smith & Nephew - TransCyte Product Line Sign up free to access full investment history, financials, executives & more

Smith & Nephew - TransCyte Product Line

Inactive
United Kingdom
Sector: Life Science Entity: Private
Merged Smith & Nephew - TransCyte Product Line merged into Shire Regenerative Medicine, Inc. in 2006
2
Transactions
Sign up to view
About Smith & Nephew - TransCyte Product Line
Operating in the Life Science industry, Smith & Nephew - TransCyte Product Line is based in United Kingdom. Investors on record include Shire Regenerative Medicine, Inc.. The company is headquartered in United Kingdom. This profile is documented within Acquity Data.
Investors
Current Investors
Shire Regenerative Medicine, Inc. ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Investment Details
2 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 2 Transactions
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Smith & Nephew - TransCyte Product Line M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Frequently Asked Questions
What does Smith & Nephew - TransCyte Product Line do?
Operating in the Life Science industry, Smith & Nephew - TransCyte Product Line is based in United Kingdom. Investors on record include Shire Regenerative Medicine, Inc.. The company is headquartered in United Kingdom. This profile is documented within Acquity Data.
Where is Smith & Nephew - TransCyte Product Line headquartered?
Smith & Nephew - TransCyte Product Line is headquartered in United Kingdom.
When was Smith & Nephew - TransCyte Product Line founded?
Founded year information for Smith & Nephew - TransCyte Product Line is available on AcquityData.
What sector is Smith & Nephew - TransCyte Product Line in?
Smith & Nephew - TransCyte Product Line operates in the Life Science sector.
Who are the investors in Smith & Nephew - TransCyte Product Line?
Current investors in Smith & Nephew - TransCyte Product Line include Shire Regenerative Medicine, Inc.. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Smith & Nephew - TransCyte Product Line been involved in?
Smith & Nephew - TransCyte Product Line has 2 transactions tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full Smith & Nephew - TransCyte Product Line profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Smith & Nephew - TransCyte Product Line's complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial